正在加载视频...
视频加载失败
It has been fun seeing how commercially available options around polygenic risk score selection have evolved over the past five years. Herasight has emerged as *the* player to watch. Loved having Jonathan Anomaly on the pod to discuss what Herasight is up to!
0 条评论
暂无评论
原始帖子的评论将显示在这里
